• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Recent changes in the package insert for succinylcholine chloride: should this drug be contraindicated for routine use in children and adolescents? (Summary of the discussions of the anesthetic and life support drug advisory meeting of the Food and Drug Administration, FDA building, Rockville, MD, June 9, 1994).

作者信息

Goudsouzian N G

出版信息

Anesth Analg. 1995 Jan;80(1):207-8. doi: 10.1097/00000539-199501000-00039.

DOI:10.1097/00000539-199501000-00039
PMID:7802287
Abstract
摘要

相似文献

1
Recent changes in the package insert for succinylcholine chloride: should this drug be contraindicated for routine use in children and adolescents? (Summary of the discussions of the anesthetic and life support drug advisory meeting of the Food and Drug Administration, FDA building, Rockville, MD, June 9, 1994).氯化琥珀胆碱包装说明书的近期变化:该药物是否应被列为儿童和青少年常规使用的禁忌药?(1994年6月9日于马里兰州罗克维尔市食品药品监督管理局大楼召开的麻醉与生命支持药物咨询会议讨论总结)
Anesth Analg. 1995 Jan;80(1):207-8. doi: 10.1097/00000539-199501000-00039.
2
FDA group urges sux label reduced to "warning".美国食品药品监督管理局小组敦促将琥珀胆碱标签降为“警告”。
J Clin Monit. 1995 Mar;11(2):141-3. doi: 10.1007/BF01617738.
3
Lessons learned from independent central review.独立中央审查的经验教训。
Eur J Cancer. 2009 Jan;45(2):268-74. doi: 10.1016/j.ejca.2008.10.031.
4
Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule.处方药产品;患者用药指导手册要求——食品药品监督管理局。最终规则。
Fed Regist. 1981 Jan 2;46(1):28-30.
5
Contraindicated use of cisapride: impact of food and drug administration regulatory action.西沙必利的禁忌使用:食品药品监督管理局监管行动的影响
JAMA. 2000 Dec 20;284(23):3036-9. doi: 10.1001/jama.284.23.3036.
6
Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule.
Fed Regist. 1981 Jan 2;46(1):28.
7
Sux debate shows process of drug education: committee chair details events.舒喘宁辩论展示了药物教育过程:委员会主席详述相关事件。
J Clin Monit. 1995 Mar;11(2):143-4. doi: 10.1007/BF01617739.
8
Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.将患者观点纳入药物研发与沟通:2001年2月16日美国食品药品监督管理局患者报告结局(PRO)协调小组会议特别工作组报告
Value Health. 2003 Sep-Oct;6(5):522-31. doi: 10.1046/j.1524-4733.2003.65309.x.
9
[Anesthetic complications. The incidence of severe anesthetic complications in patients and families with progressive muscular dystrophy of the Duchenne and Becker types].[麻醉并发症。杜兴氏和贝克氏型进行性肌营养不良患者及其家属中严重麻醉并发症的发生率]
Anaesthesist. 2000 Mar;49(3):187-95. doi: 10.1007/s001010050813.
10
Panel recommends limits on alcohol content of nonprescription products. FDA Over-The-Counter Drugs Advisory Committee.专家组建议对非处方产品的酒精含量加以限制。美国食品药品监督管理局非处方药物咨询委员会。
Am J Hosp Pharm. 1993 Mar;50(3):400.

引用本文的文献

1
Succinylcholine use in Patients 8 Years and Younger is NOT Zero While Midazolam use in Patients 65 Years and Older is NOT Decreasing Anymore: A 14-Year Census Report from a Tertiary Care Medical Center in the United States.8岁及以下患者使用琥珀酰胆碱的情况并非为零,而65岁及以上患者使用咪达唑仑的情况不再减少:来自美国一家三级医疗中心的14年人口普查报告。
Ann Card Anaesth. 2025 Jan 1;28(1):84-88. doi: 10.4103/aca.aca_112_24. Epub 2024 Nov 19.
2
Use of Succinylcholine by Anaesthetists in Turkey: A National Survey.土耳其麻醉医生使用琥珀酰胆碱的情况:一项全国性调查。
Turk J Anaesthesiol Reanim. 2015 Oct;43(5):323-31. doi: 10.5152/TJAR.2015.03708. Epub 2015 Aug 21.
3
Improved outcomes in paediatric anaesthesia: contributing factors.
小儿麻醉效果的改善:促成因素
Pediatr Surg Int. 2012 Jun;28(6):553-61. doi: 10.1007/s00383-012-3101-y. Epub 2012 May 12.
4
[Anesthetic management of pediatric cleft lip and cleft palate repair].
Anaesthesist. 2005 May;54(5):455-66. doi: 10.1007/s00101-005-0823-4.
5
Adverse effects of neuromuscular blockers and their antagonists.神经肌肉阻滞剂及其拮抗剂的不良反应。
Drug Saf. 1998 Feb;18(2):99-116. doi: 10.2165/00002018-199818020-00002.